Gyre Therapeutics (GYRE) Prepaid Assets (2010 - 2026)
Gyre Therapeutics (GYRE) reported Prepaid Assets of $3.8 million for Q1 2026, down 53.9% year-over-year from $8.2 million in Q1 2025, and up 33.07% quarter-over-quarter from $2.8 million in Q4 2025.
Gyre Therapeutics (GYRE) Prepaid Assets (2010 - 2026) Analysis & Trends
Gyre Therapeutics (GYRE) has 17 years of Prepaid Assets data on file, last reported at $3.8 million in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $3.8 million, down 53.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.8 million (down 53.9% YoY), and the FY2025 annual result was $2.8 million, up 96.87% from the prior year.
- Prepaid Assets advanced to $3.8 million in Q1 2026 per GYRE's latest filing, from $2.8 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $8.2 million in Q1 2025 and troughed at $377000.0 in Q4 2022.
- A 5-year average of $2.1 million and a median of $1.4 million in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2025: Prepaid Assets plunged 89.03% in 2022, then soared 330.21% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $377000.0 in 2022, then soared by 177.19% to $1.0 million in 2023, then jumped by 37.42% to $1.4 million in 2024, then soared by 96.87% to $2.8 million in 2025, then soared by 33.07% to $3.8 million in 2026.
- Business Quant data shows GYRE's Prepaid Assets at $3.8 million in Q1 2026, $2.8 million in Q4 2025, and $2.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Gyre Therapeutics | 554.75 Mn | 540.62 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.76 Mn |
| Dec 31, 2025 | 2.83 Mn |
| Sep 30, 2025 | 2.87 Mn |
| Jun 30, 2025 | 2.70 Mn |
| Mar 31, 2025 | 8.16 Mn |
| Dec 31, 2024 | 1.44 Mn |
| Sep 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 1.72 Mn |
| Mar 31, 2024 | 1.90 Mn |
| Dec 31, 2023 | 1.05 Mn |
| Sep 30, 2023 | 1.17 Mn |
| Jun 30, 2023 | 697,000.00 |
| Mar 31, 2023 | 915,000.00 |
| Dec 31, 2022 | 377,000.00 |
| Sep 30, 2022 | 2.16 Mn |
| Jun 30, 2022 | 914,000.00 |
| Mar 31, 2022 | 1.32 Mn |
| Dec 31, 2021 | 2.81 Mn |
| Sep 30, 2021 | 8.32 Mn |
| Jun 30, 2021 | 8.33 Mn |